AVE 0.00% 0.3¢ avecho biotechnology limited

poh negatives, page-3

  1. 1,879 Posts.
    I hope POH’s management will blow our uncertainly away by delivering a result of the 2-nd oxycodone trial soon. According to the article posted earlier, the second phase of oxycodone trial is scheduled to be completed before the end of this year (means December 2009). Let's wait and see.

    Extract:
    “Our next trial, scheduled to be completed before the end of this year, will involve a repeat daily dosing study and will examine oxycodone blood levels over a longer period.

    “We hope to show that oxycodone may be useful for the reduction of pain on a 24/7 basis.”

    Nj
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $205 72.91K

Buyers (Bids)

No. Vol. Price($)
62 90468113 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 61728026 18
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.